Difference between revisions of "MEDICATION-LIGNOCAINE"
From NeuroRehab.wiki
(Imported from text file) |
(Imported from text file) |
||
| Line 4: | Line 4: | ||
<br/> | <br/> | ||
<br/>SE | <br/>SE | ||
<br/>3. Nausea & vomiting. | <br/>3. Nausea & vomiting. | ||
<br/> | |||
<br/>4. CNS: slurred speech, drowsiness, seizures. | <br/>4. CNS: slurred speech, drowsiness, seizures. | ||
<br/>5. CVS: bradycardia, heart block, asystole. | <br/>5. CVS: bradycardia, heart block, asystole. | ||
<br/> | <br/> | ||
<br/>DOSAGE | <br/>DOSAGE | ||
<br/>6. Initially 1 mg/kg bolus after the third DC shock, additional bolus of 0.5 mg/kg (up to 200 mg) may be considered. | <br/>6. Initially 1 mg/kg bolus after the third DC shock, additional bolus of 0.5 mg/kg (up to 200 mg) may be considered. | ||
[[Category:Medication]] | [[Category:Medication]] | ||
[[Category:Advanced Life Support]] | [[Category:Advanced Life Support]] | ||
Latest revision as of 11:31, 1 January 2023
SUMMARY
1. Acts as a membrane stabilising agent, used for its anti-arrhythmic effects.
2. Indications: VF/pulseless or VT refractory to defibrillation.
SE
3. Nausea & vomiting.
4. CNS: slurred speech, drowsiness, seizures.
5. CVS: bradycardia, heart block, asystole.
DOSAGE
6. Initially 1 mg/kg bolus after the third DC shock, additional bolus of 0.5 mg/kg (up to 200 mg) may be considered.
